Carnexiv
NDC Package 67386-621-52

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Carnexiv is a . Marketed by Lundbeck Pharmaceuticals Llc, this product is identified by NDC 67386-621 and is authorized under FDA application NDA206030.

Identification & Billing

NDC Package Code
67386-621-52
Package Description
1 VIAL, GLASS in 1 CARTON / 20 mL in 1 VIAL, GLASS
Product Code
67386-621
11-Digit Billing Format
67386062152

Clinical Specifications

Proprietary Name
Carnexiv
Dosage Form
-

Regulatory & Marketing

Labeler Name
Lundbeck Pharmaceuticals Llc
FDA Application #
NDA206030
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-21-2014
End Marketing Date
02-06-2025
Listing Expiration
02-06-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67386-621-52 identifies a specific commercial package of 1 vial, glass in 1 carton / 20 ml in 1 vial, glass of Carnexiv, labeled by Lundbeck Pharmaceuticals Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Lundbeck Pharmaceuticals Llc on October 21, 2014. The current certification is valid through February 06, 2025.

How is this Lundbeck Pharmaceuticals Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67386062152. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67386-621-52
11-Digit CMS (5-4-2)
67386-0621-52

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.